Back

Utility of NT-proBNP for detecting heart failure and assessing prognosis in elderly myocardial infarction survivors: insights from the OMEMI trial

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Haemodynamics in acute heart failure Biomarkers Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Peder Langeland Myhre

Oslo University Hospital Rikshospitalet, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
The effect of Pecavaptan in patients with heart failure with reduced versus preserved ejection fraction - a post hoc analysis of the AVANTI trial
Mr G. Voordes (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Renal response to a dual vasopressin antagonist in acute heart failure: a post-hoc analysis from the AVANTI trial
Doctor L. Cosic (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Oxygen uptake recovery and impaired cardiac reserve capacity: interaction with tau parameter
Doctor G. Crisci (Hasselt, BE)
Abstract Slides

Access the full session

Session thumbnail
Haemodynamics in acute heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Biomarkers definning pathophysiology and prognosis
thumbnail
Congress Session
Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure
thumbnail
Congress Session
Biomarkers to guide the treatment of heart failure: where are we going?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources